Trump Administration's FY2027 R&D memo shifts federal science priorities from climate/equity focus to national security and ...
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced changes to its executive leadership team to further advance its aspirations to discover and develop new medicines and vaccines, with ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Yesterday, the Biden Administration announced new efforts to “advance the ...
The Discovery, Research, Innovation for a Vibrant Economy (DRIVE) team, which Healey created via executive order in August, ...
This year, the Department of Defense was authorized to spend $34 billion more on research and development than it was two years ago and only $18 billion more on procurement of new aircraft and ships.
Maxwell Biosciences (“MaxwellIndustry-leading talent joins leadership team as company accelerates its CLAROMER™ drug platform Tony Verco, MD, MBA, appointed Chief Medical Officer Beth Burnside, PhD, ...
Sitting in an executive roundtable led by the executive director of the Colorado Society of Association Executives, I listened as leaders from various nonprofit associations shared their strategies ...
A total of 22 mRNA vaccine development contracts totaling roughly $500 million have been canceled, the Department of Health and Human Services (HHS) announced Tuesday. The mRNA investments were part ...
Shanghai and Suzhou, TOKYO--(BUSINESS WIRE)--Elpiscience Biopharma, Ltd. (Chairman and CEO: Darren Ji, MD, Ph.D., “Elpiscience”) and Astellas Pharma Inc. (TSE ...
SHANGHAI and SUZHOU, China and TOKYO, Dec. 28, 2023 /PRNewswire/ -- Elpiscience Biopharma, Ltd. (Chairman and CEO: Darren Ji, MD, Ph.D., "Elpiscience") and Astellas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results